Swiss Electrical Stock News

Readers hoping to buy Julius Bär Gruppe AG ( VTX:BAER ) for its dividend will need to make their move shortly, as the...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Emmi AG...

Roche’s new cobas MPX-E assay and why it matters for shareholders Roche Holding (SWX:ROG) has launched its cobas MPX-E multiplex assay in CE mark countries, offering simultaneous screening for HIV, HCV, HBV and HEV on existing cobas x800 systems to support higher throughput donor testing. See our latest analysis for Roche Holding. Roche’s share price has softened recently, with a 30 day share price return of 10.47% and a year to date share price return of a 0.98% decline, even though the 1...

As European markets experience a positive shift, with the STOXX Europe 600 Index gaining 3.92% amid hopes for a shorter-lived Middle East conflict, investors are keenly observing how energy market volatility and inflation trends might impact dividend stocks. In this context, selecting robust dividend stocks involves considering companies with strong financial health and stable cash flows that can weather economic fluctuations while continuing to provide reliable income streams.

Dividend announcement puts yield in focus for BCGE Banque Cantonale de Genève (SWX:BCGE) has announced an annual dividend of CHF 0.5250 per share, with the stock trading ex dividend on 5 May 2026 and payment scheduled for 7 May 2026. See our latest analysis for Banque Cantonale de Genève. The dividend news follows a strong run in the shares, with a 30 day share price return of 12.38% and a 90 day share price return of 40.48%. The 1 year total shareholder return of 48.30% highlights how...

If you are wondering whether UBS Group's current share price reflects its true worth, you are not alone. That is exactly what this article is here to unpack. UBS Group closed at CHF31.16 recently, with returns of 1.4% over the past 7 days, 4.4% over the past 30 days, a year to date return of negative 18.4%, 39.6% over 1 year, 79.1% over 3 years and 141.6% over 5 years, hinting at shifting expectations around both opportunity and risk. Recent coverage has focused on UBS Group's ongoing...

Wondering if Logitech International at around $73.32 is offering genuine value or just riding sentiment? This article breaks down what the current share price might be implying about the business. The stock has returned 1.3% over the last 7 days and 4.6% over the last 30 days, set against a year to date return of a 7.8% decline and a 25.7% return over 1 year, with a 49.7% return over 3 years and a 21.4% decline over 5 years. Recent coverage has focused on Logitech International as an...

If you are wondering whether Novartis at around CHF123 per share still offers value, the key is to look past the headline price and focus on what you are actually getting for each franc invested. The stock has returned 1.9% over the last week, is roughly flat over 30 days, and has delivered 13.5% year to date alongside 43.2% over 1 year, 65.7% over 3 years, and 96.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent attention...

Why Nestlé (SWX:NESN) is on investors’ radar today Nestlé (SWX:NESN) continues to attract attention as investors reassess large consumer staples groups, with the share price around CHF 78.37 and recent returns mixed across the past month and past 3 months. See our latest analysis for Nestlé. While the share price is around CHF78.37 with a 90 day share price return of 2.90%, the 1 year total shareholder return of 2.91% decline and 3 year total shareholder return of 24.37% decline point to...

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite have shown resilience with notable gains, reflecting a cautiously optimistic sentiment amid geopolitical uncertainties. In such an environment, growth companies with significant insider ownership often attract attention due to their potential for alignment between management and shareholder interests, which can be particularly appealing when navigating...

As European markets navigate through the complexities of Middle East tensions and energy market volatility, recent gains in indices like the STOXX Europe 600 and Germany’s DAX suggest a cautiously optimistic sentiment among investors. In such an environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.

As European markets show resilience with the STOXX Europe 600 Index rising by 3.92%, investor sentiment is buoyed by hopes of a shorter-than-expected Middle East conflict and robust gains in major indices like Germany’s DAX and the UK’s FTSE 100. In this environment, growth companies with high insider ownership can offer unique opportunities, as they often signal strong confidence from those closest to the business, aligning their interests with shareholders during volatile times.

Swiss Prime Site (SWX:SPSN) has moved after the company appointed Martina Moosmann as Chief Financial Officer, formalising succession after an interim period and providing investors with fresh information about its senior financial leadership. See our latest analysis for Swiss Prime Site. The appointment appears to have sparked fresh interest, with the share price at CHF138.4 after a 1 day share price return of 1.10% and 7 day share price return of 4.93%. A 90 day share price return of 13.07%...

Roche Holding (SWX:ROP) has received CE marking for its cobas MPX-E assay, enabling simultaneous screening for HIV, hepatitis C, B, and E in blood donations. The company has also launched the cobas eplex RP3 respiratory panel, designed to test for up to 25 respiratory pathogens in a single rapid assay. These diagnostics products target blood safety, laboratory efficiency, and faster respiratory infection diagnosis across clinical settings. Roche Holding, trading at around CHF318.0,...

Amrize (SWX:AMRZ) has completed the acquisition of PB Materials Holdings, adding 26 locations across West Texas. The move increases Amrize’s presence in a region with significant infrastructure and energy related project activity. The transaction reflects Amrize’s push to grow business lines that are less tied to the residential construction cycle. Amrize, listed as SWX:AMRZ, now trades at CHF43.64 per share, with the stock showing a 0.8% decline over the past week and a 1.9% decline year...

Partners Group Holding (SWX:PGHN) has appointed Pete Zippelius as Co-Head of its Private Equity Health & Life vertical, sharpening its focus on healthcare and life sciences. The firm is also reported to be in early discussions to acquire a significant stake in Happiest Minds Technologies alongside other private equity investors. Partners Group Holding, trading at around CHF866.0, has seen mixed share performance, with a 4.2% gain over the past week and 5.6% over the past month, set against...

In March 2026, Sonova Holding AG announced plans to sell its Consumer Hearing business, which markets premium audio products under the Sennheiser brand, and said it will classify this unit as discontinued operations in its 2026 financial results. The move highlights a sharpened focus on Sonova’s core innovation areas in hearing care, while it simultaneously explores geo-targeted retail acquisitions to reshape its portfolio. Next, we’ll examine how exiting the Sennheiser-branded Consumer...

Recent performance snapshot Partners Group Holding (SWX:PGHN) has drawn attention after a recent share price move, with the stock up 2.6% over the past day and 4.6% over the past week on the Swiss market. See our latest analysis for Partners Group Holding. That short term momentum contrasts with a 90 day share price return of an 11.62% decline and a 1 year total shareholder return showing a 27.63% loss, while the 3 year total shareholder return of 16.27% points to a stronger longer run...

In March 2026, Julius Bär Gruppe AG announced it would exercise its option to redeem all outstanding Perpetual Tier 1 Subordinated Bonds (ISIN: XS2238020445), originally issued on 8 October 2020 with a 4.875% coupon and an aggregate nominal amount of US$350,000,000, at par plus accrued interest on the first call date of 8 April 2026. This early redemption under condition 3(c) highlights Julius Bär’s active approach to capital structure management, reflecting how it balances funding costs,...

Lonza recently published its 2025 Annual and Sustainability Reports, called its 2026 Annual General Meeting for 8 May in Basel, and proposed a 25% dividend increase alongside a broad board refresh. The nomination of former Eli Lilly executive Stephen Fry and other new directors with healthcare, automation, AI and biopharma expertise underscores Lonza’s emphasis on governance quality and future-focused capabilities in its core CDMO business. We’ll now explore how Lonza’s planned 25% dividend...

MCH Group AG ( VTX:MCHN ) just released a solid earnings report, and the stock displayed some strength. However, we...

Amid ongoing geopolitical tensions and fluctuating energy prices, European markets have experienced mixed performance, with the pan-European STOXX Europe 600 Index seeing a modest gain. In this uncertain environment, identifying stocks trading below their estimated fair value can present potential opportunities for investors seeking to capitalize on market inefficiencies.

In March 2026, Emmi AG was removed from the FTSE All-World Index, altering its representation in a widely followed global equity benchmark. This index removal may influence how index-tracking institutional investors allocate capital to Emmi, potentially reshaping its visibility in global portfolios. Next, we will examine how Emmi's removal from the FTSE All-World Index may influence its investment narrative and investor perception. Capitalize on the AI infrastructure supercycle with our...

SoftwareOne Holding (SWX:SWON) has put fresh numbers on the table for FY 2025, with first half revenue of CHF 486.6 million and basic EPS of CHF 0.07, while the trailing twelve months show revenue of CHF 1.2 billion and basic EPS of CHF 0.13. Over the past reported periods, revenue has moved from CHF 529.2 million and EPS of CHF 0.18 in the first half of 2024 to CHF 486.2 million and an EPS loss of CHF 0.19 in the second half of 2024, before landing at the latest CHF 486.6 million and CHF...